Click here for a description of the charts and data table
Please tell us if you are using this feature and what you think!
ChEMBL ligand: CHEMBL259850 (AR-A014418) |
---|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
There should be some charts here, you may need to enable JavaScript!
|
DB | Assay description | Assay Type | Standard value | Standard parameter | Original value | Original units | Original parameter | Reference |
---|---|---|---|---|---|---|---|---|
acetylcholinesterase (Yt blood group)/Acetylcholinesterase in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL3198] [GtoPdb: 2465] [UniProtKB: P21836] | ||||||||
ChEMBL | Inhibition of mouse AChE using acetylthiocholine iodide as substrate incubated for 20 mins by Ellman's method | B | 4.4 | pIC50 | >40000 | nM | IC50 | J Med Chem (2021) 64: 7483-7506 [PMID:34024109] |
cyclin dependent kinase 2/Cyclin-dependent kinase 2 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL301] [GtoPdb: 1973] [UniProtKB: P24941] | ||||||||
ChEMBL | Inhibition of Cdk2 | B | 4 | pIC50 | >100000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
ChEMBL | Inhibition of CDK2 at 10 mM | B | 4 | pIC50 | 100000 | nM | IC50 | Trends Pharmacol Sci (2004) 25: 471-480 [PMID:15559249] |
cyclin dependent kinase 5/Cyclin-dependent kinase 5 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL4036] [GtoPdb: 1977] [UniProtKB: Q00535] | ||||||||
ChEMBL | Inhibition of CDK5 at 10 mM | B | 4 | pIC50 | 100000 | nM | IC50 | Trends Pharmacol Sci (2004) 25: 471-480 [PMID:15559249] |
Cyclin-dependent kinase 5 regulatory subunit 1 in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2783] [UniProtKB: Q15078] | ||||||||
ChEMBL | Inhibition of Cdk5 | B | 4 | pIC50 | >100000 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
autophagy related 4B cysteine peptidase/Cysteine protease ATG4B in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1741221] [GtoPdb: 2329] [UniProtKB: Q9Y4P1] | ||||||||
ChEMBL | Inhibition of ATG4B (unknown origin) incubated up to 1 hr in presence of fluorescent protein substrate by FRET-based-LC3 cleavage assay | B | 5.8 | pIC50 | 1600 | nM | IC50 | WO-2017027984-A1. Compounds and methods for treatment of cancer by inhibiting atg4b and blocking autophagy (2017) |
glycogen synthase kinase 3 alpha/Glycogen synthase kinase-3 alpha in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL2850] [GtoPdb: 2029] [UniProtKB: P49840] | ||||||||
ChEMBL | Inhibition of human GSK3alpha activity using Ser/Thr 11 peptide as substrate by FRET assay | B | 4.15 | pIC50 | 70000 | nM | IC50 | Bioorg Med Chem Lett (2011) 21: 5610-5615 [PMID:21807510] |
glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Human (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL262] [GtoPdb: 2030] [UniProtKB: P49841] | ||||||||
ChEMBL | Inhibition of GSK-3beta using phospho-glycogen synthase peptide-2 as substrate after 10 mins by liquid scintillation counting | B | 6.11 | pKi | 770 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 2099-2101 [PMID:22321216] |
GtoPdb | - | - | 7.42 | pKi | 38 | nM | Ki | J Biol Chem (2003) 278: 45937-45 [PMID:12928438] |
ChEMBL | Inhibition of GSK3-beta | B | 7.42 | pKi | 38 | nM | Ki | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
ChEMBL | Inhibition of human GSK-3beta using biotin-AAEELDSRAGS(PO3H2)PQL as substrate after 20 mins by liquid scintillation counting | B | 7.42 | pKi | 38 | nM | Ki | Bioorg Med Chem Lett (2012) 22: 2099-2101 [PMID:22321216] |
ChEMBL | Binding affinity to human full length GSK-3 beta transfected in Sf21 cells assessed as inhibition constant measured after 6 hrs by scintillation method | B | 7.42 | pKi | 38 | nM | Ki | Bioorg Med Chem (2023) 92: 117406-117406 [PMID:37536264] |
ChEMBL | Inhibition of human recombinant GSK-3beta using prephosphorylated polypeptide as substrate incubated for 30 mins in presence of ATP by Kinase-Glo luminescence assay | B | 6.31 | pIC50 | 490 | nM | IC50 | J Med Chem (2021) 64: 7483-7506 [PMID:34024109] |
ChEMBL | Inhibition of human GSK-3beta using YRRAAVPPSPSLSRHSSPHQS(p) EDEEE substrate peptide and [gamma-33P-ATP] incubated for 40 mins by scintillation counting method | B | 6.66 | pIC50 | 220 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 160-166 [PMID:29208522] |
ChEMBL | Inhibition of human recombinant GSK3beta | B | 6.98 | pIC50 | 104 | nM | IC50 | J Med Chem (2011) 54: 8461-8470 [PMID:22050263] |
ChEMBL | Inhibition of GSK3beta | B | 6.98 | pIC50 | 104 | nM | IC50 | J Med Chem (2012) 55: 9107-9119 [PMID:22489897] |
ChEMBL | Inhibition of GSK3-beta | B | 6.98 | pIC50 | 104 | nM | IC50 | Proc Natl Acad Sci U S A (2007) 104: 20523-20528 [PMID:18077363] |
ChEMBL | Inhibition of GSK3-beta | B | 6.98 | pIC50 | 104 | nM | IC50 | Trends Pharmacol Sci (2004) 25: 471-480 [PMID:15559249] |
ChEMBL | Inhibition of recombinant full length human GSK3beta expressed in Sf21 insect cells using biotinylated-AAEELDSRAGS(PO3H2)PQL peptide as substrate preincubated enzyme-substrate mixture for 15 to 20 mins followed by [gamma-33P]ATP addition and measured after 20 mins by scintillation proximity assay | B | 6.98 | pIC50 | 104 | nM | IC50 | ACS Med Chem Lett (2020) 11: 825-831 [PMID:32435391] |
ChEMBL | Inhibition of human GSK3-beta | B | 7 | pIC50 | 100 | nM | IC50 | Eur J Med Chem (2009) 44: 2361-2371 [PMID:18929433] |
ChEMBL | Inhibition of recombinant human GSK3beta using biotin-AAEELDSRAGS(PO3H2)PQL as substrate preincubated for 10 to 15 mins followed by [gamma33P]ATP addition after 20 mins by scintillation proximity assay | B | 7 | pIC50 | 100 | nM | IC50 | Eur J Med Chem (2017) 125: 464-477 [PMID:27689729] |
ChEMBL | Inhibition of recombinant human GSK3beta using prephosphorylated peptide as substrate measured after 30 mins by Kinase-glo luminescence assay | B | 7.14 | pIC50 | 72 | nM | IC50 | Bioorg Med Chem Lett (2019) 29: 1597-1600 [PMID:31054862] |
ChEMBL | Inhibition of human GSK3-beta by scintillation counting | B | 7.38 | pIC50 | 41.8 | nM | IC50 | J Med Chem (2009) 52: 1853-1863 [PMID:19338355] |
ChEMBL | Inhibition of recombinant full length human His-tagged GSK3beta expressed in baculovirus expression system using ser/thr-9 peptide as substrate measured after 1 hr by Z'-Lyte assay | B | 8.68 | pIC50 | 2.07 | nM | IC50 | Medchemcomm (2018) 9: 1472-1490 [PMID:30288222] |
glycogen synthase kinase 3 beta/Glycogen synthase kinase-3 beta in Mouse (target type: SINGLE PROTEIN) [ChEMBL: CHEMBL1075321] [GtoPdb: 2030] [UniProtKB: Q9WV60] | ||||||||
ChEMBL | Inhibition of human GSK-3beta in mouse 3T3 fibroblasts stably expressing four-repeat tau protein assessed as reduction in tau S396 phosphorylation after 4 hrs post dose by Western blot | B | 7 | pIC50 | 100 | nM | IC50 | Bioorg Med Chem Lett (2018) 28: 160-166 [PMID:29208522] |
ChEMBL data shown on this page come from version 34:
Zdrazil B, Felix E, Hunter F, Manners EJ, Blackshaw J, Corbett S, de Veij M, Ioannidis H, Lopez DM, Mosquera JF, Magarinos MP, Bosc N, Arcila R, Kizilören T, Gaulton A, Bento AP, Adasme MF, Monecke P, Landrum GA, Leach AR. (2024). The ChEMBL Database in 2023: a drug discovery platform spanning multiple bioactivity data types and time periods. Nucleic Acids Res., 52(D1). DOI: 10.1093/nar/gkad1004. [EPMCID:10767899] [PMID:37933841]
Davies M, Nowotka M, Papadatos G, Dedman N, Gaulton A, Atkinson F, Bellis L, Overington JP. (2015) 'ChEMBL web services: streamlining access to drug discovery data and utilities.' Nucleic Acids Res., 43(W1). DOI: 10.1093/nar/gkv352. [EPMCID:25883136]